Immune Checkpoint Inhibitors in Uveal and Conjunctival Melanoma

Int Ophthalmol Clin. 2019 Spring;59(2):53-63. doi: 10.1097/IIO.0000000000000263.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biological Factors / therapeutic use*
  • Conjunctival Neoplasms / drug therapy*
  • Conjunctival Neoplasms / immunology
  • Humans
  • Immunotherapy / methods*
  • Melanoma / drug therapy*
  • Melanoma / immunology
  • Uveal Neoplasms / drug therapy*
  • Uveal Neoplasms / immunology

Substances

  • Biological Factors